Of importance, the frequency of EGFR mutation in patients with bronchioalveolar carcinoma was similar to that seen in patients with non-BAC adenocarcinomas (Han et al, 2005). This evidence concerns the gene EGFR and minimally invasive lung adenocarcinoma.